McKesson Corporation (MCK) Total Return CAGR:3.40%(TTM)
Over the latest trailing 12-month period, McKesson Corporation (MCK)'s total return cagr is +3.40%. The comparable SPY value is +26.75%. Year-to-date total return is -8.31%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, McKesson Corporation's Total Return CAGR averages 23.22% over 3 years and 33.07% over 5 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of McKesson Corporation's investment performance.
MCK Total Return CAGR Chart
McKesson Corporation (MCK)
MCK Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 20 quarters.
MCK Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 4289.51 | 3932.87 | -356.64 | -8.31% | -8.31% |
| 2025 | 2967.64 | 4289.51 | +1321.87 | +44.54% | +44.54% |
| 2024 | 2399.59 | 2967.64 | +568.05 | +23.67% | +23.67% |
| 2023 | 1933.08 | 2399.59 | +466.50 | +24.13% | +24.13% |
| 2022 | 1273.25 | 1933.08 | +659.83 | +51.82% | +51.82% |
| 2021 | 882.84 | 1273.25 | +390.42 | +44.22% | +44.22% |
| 2020 | 694.74 | 882.84 | +188.09 | +27.07% | +27.07% |
| 2019 | 548.22 | 694.74 | +146.52 | +26.73% | +26.73% |
| 2018 | 765.59 | 548.22 | -217.37 | -28.39% | -28.39% |
| 2017 | 683.90 | 765.59 | +81.69 | +11.94% | +11.94% |
| 2016 | 953.89 | 683.90 | -269.99 | -28.30% | -28.30% |
| 2015 | 999.01 | 953.89 | -45.12 | -4.52% | -4.52% |
| 2014 | 772.86 | 999.01 | +226.15 | +29.26% | +29.26% |
| 2013 | 460.92 | 772.86 | +311.94 | +67.68% | +67.68% |
| 2012 | 367.00 | 460.92 | +93.92 | +25.59% | +25.59% |
| 2011 | 328.32 | 367.00 | +38.68 | +11.78% | +11.78% |
| 2010 | 288.51 | 328.32 | +39.81 | +13.80% | +13.80% |
| 2009 | 177.03 | 288.51 | +111.48 | +62.97% | +62.97% |
| 2008 | 296.88 | 177.03 | -119.85 | -40.37% | -40.37% |
| 2007 | 228.85 | 296.88 | +68.03 | +29.72% | +29.72% |
| 2006 | 231.76 | 228.85 | -2.91 | -1.26% | -1.26% |
| 2005 | 140.55 | 231.76 | +91.22 | +64.90% | +64.90% |
| 2004 | 142.55 | 140.55 | -2.00 | -1.40% | -1.40% |
| 2003 | 118.86 | 142.55 | +23.69 | +19.93% | +19.93% |
| 2002 | 163.24 | 118.86 | -44.38 | -27.19% | -27.19% |
| 2001 | 155.58 | 163.24 | +7.66 | +4.92% | +4.92% |
| 2000 | 96.48 | 155.58 | +59.11 | +61.26% | +61.26% |
| 1999 | 336.60 | 96.48 | -240.12 | -71.34% | -71.34% |
| 1998 | 229.07 | 336.60 | +107.53 | +46.94% | +46.94% |
| 1997 | 116.70 | 229.07 | +112.37 | +96.29% | +96.29% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 3,933 | -14.6% | +3.4% |
| Q1 2026 | 4,604 | +7.3% | +32.2% |
| Q4 2025 | 4,289 | +17.6% | +42.8% |
| Q3 2025 | 3,648 | -4.1% | +38.9% |
| Q2 2025 | 3,804 | +9.2% | +21.4% |
| Q1 2025 | 3,483 | +16.0% | +26.4% |
| Q4 2024 | 3,003 | +14.3% | +26.7% |
| Q3 2024 | 2,627 | -16.2% | +14.2% |
| Q2 2024 | 3,133 | +13.8% | +46.2% |
| Q1 2024 | 2,754 | +16.1% | +54.0% |
| Q4 2023 | 2,371 | +3.1% | +22.5% |
| Q3 2023 | 2,300 | +7.3% | +31.5% |
| Q2 2023 | 2,143 | +19.8% | +27.9% |
| Q1 2023 | 1,789 | -7.6% | +13.5% |
| Q4 2022 | 1,935 | +10.7% | +54.0% |
| Q3 2022 | 1,749 | +4.3% | +68.4% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About McKesson Corporation
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Brian S. Tyler